[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Wang et al., 2013 - Google Patents

Determination of CK2 specificity and substrates by proteome-derived peptide libraries

Wang et al., 2013

Document ID
2225798891697811459
Author
Wang C
Ye M
Bian Y
Liu F
Cheng K
Dong M
Dong J
Zou H
Publication year
Publication venue
Journal of proteome research

External Links

Snippet

Understanding the specificity of kinases enables prediction of their substrates and uncovering kinase functions in signaling pathways. Traditionally synthesized peptide libraries are used to determine the kinase specificity. In this study, a proteomics-based …
Continue reading at pubs.acs.org (other versions)

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6842Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848Methods of protein analysis involving mass spectrometry
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography

Similar Documents

Publication Publication Date Title
Malik et al. Quantitative analysis of the human spindle phosphoproteome at distinct mitotic stages
Wang et al. Determination of CK2 specificity and substrates by proteome-derived peptide libraries
Wisniewski et al. Consecutive proteolytic digestion in an enzyme reactor increases depth of proteomic and phosphoproteomic analysis
Dau et al. Proteomics using protease alternatives to trypsin benefits from sequential digestion with trypsin
Shiromizu et al. Identification of missing proteins in the neXtProt database and unregistered phosphopeptides in the PhosphoSitePlus database as part of the Chromosome-centric Human Proteome Project
Chapman et al. Mapping PARP-1 auto-ADP-ribosylation sites by liquid chromatography–tandem mass spectrometry
Tsai et al. Immobilized metal affinity chromatography revisited: pH/acid control toward high selectivity in phosphoproteomics
Cantin et al. Quantitative phosphoproteomic analysis of the tumor necrosis factor pathway
Bantscheff et al. Chemoproteomic approaches to drug target identification and drug profiling
Crowe et al. Ubiquitin chain enrichment middle-down mass spectrometry enables characterization of branched ubiquitin chains in cellulo
Chang et al. Analysis of protein phosphorylation by hypothesis-driven multiple-stage mass spectrometry
Petkowski et al. Substrate specificity of mammalian N-terminal α-amino methyltransferase NRMT
Lemeer et al. Online automated in vivo zebrafish phosphoproteomics: from large-scale analysis down to a single embryo
Kanshin et al. Sample preparation and analytical strategies for large-scale phosphoproteomics experiments
Turk Understanding and exploiting substrate recognition by protein kinases
Wang et al. Antibody-free approach for the global analysis of protein methylation
De Graaf et al. Signal transduction reaction monitoring deciphers site-specific PI3K-mTOR/MAPK pathway dynamics in oncogene-induced senescence
Kaushik et al. The expression pattern of the phosphoproteome is significantly changed during the growth phases of recombinant CHO cell culture
Zhang et al. Comparison of three quantitative phosphoproteomic strategies to study receptor tyrosine kinase signaling
Dong et al. Depletion of acidic phosphopeptides by SAX to improve the coverage for the detection of basophilic kinase substrates
Zhou et al. Online Nanoflow RP− RP-MS Reveals Dynamics of Multicomponent Ku Complex in Response to DNA Damage
Kaleja et al. Combination of SCX fractionation and charge-reversal derivatization facilitates the identification of nontryptic peptides in C-terminomics
Lu et al. Combinatorial histone H3 modifications are dynamically altered in distinct cell cycle phases
Xu et al. Mass spectrometry analysis of phosphopeptides after peptide carboxy group derivatization
Moran et al. Emerging applications for phospho-proteomics in cancer molecular therapeutics